Trial intelligence / Profile preview

Hydroxychloroquine vs Clobetasol for Oral Lichen Planus

NCT00102557Phase 2Completed

Sponsor
National Institute of Dental and Craniofacial Research
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hydroxychloroquine in oral lichen planus (OLP), sponsored by National Institute of Dental and Craniofacial Research. Started Jan 2005; status: completed.

02

Drugs

hydroxychloroquine
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT00102557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00102557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call